SEC Form 4 · accession 0001645627-17-000096
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jul 18, 2017
Accepted (ET)
Jul 21, 2017 · 3:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 18, 2017 | P | 5,000 | $0.0253 | A | 21,713,819 | D | |
| Common Stock | Jul 18, 2017 | P | 2,000 | $0.0254 | A | 21,715,819 | D | |
| Common Stock | Jul 18, 2017 | P | 5,000 | $0.0269 | A | 21,720,819 | D | |
| Common Stock | Jul 18, 2017 | P | 5,000 | $0.0269 | A | 21,725,819 | D | |
| Common Stock | Jul 18, 2017 | P | 2,000 | $0.0267 | A | 21,727,819 | D | |
| Common Stock | Jul 18, 2017 | P | 3,500 | $0.0269 | A | 21,731,319 | D | |
| Common Stock | Jul 18, 2017 | P | 2,000 | $0.0267 | A | 21,733,319 | D | |
| Common Stock | Jul 18, 2017 | P | 700 | $0.0269 | A | 21,734,019 | D | |
| Common Stock | Jul 18, 2017 | P | 5,000 | $0.0249 | A | 21,739,019 | D | |
| Common Stock | Jul 18, 2017 | P | 5,000 | $0.0249 | A | 21,744,019 | D | |
| Common Stock | Jul 18, 2017 | P | 2,000 | $0.0269 | A | 21,746,019 | D | |
| Common Stock | Jul 18, 2017 | P | 5,000 | $0.025 | A | 21,751,019 | D | |
| Common Stock | Jul 18, 2017 | P | 10,000 | $0.025 | A | 21,761,019 | D | |
| Common Stock | Jul 18, 2017 | P | 10,000 | $0.0246 | A | 21,771,049 | D |
Table II — derivative securities
No Table II lines on this filing.